DD212982A5 - Verfahren zur herstellung von rinder-wachstumshormon-aehnlichen polypeptiden - Google Patents

Verfahren zur herstellung von rinder-wachstumshormon-aehnlichen polypeptiden Download PDF

Info

Publication number: DD212982A5
Authority: DD; German Democratic Republic
Prior art keywords: bgh; growth hormone; dna; bovine growth; sequence
Prior art date: 1982-08-17

Application number

DD83254030A

Other languages

German (de)

English (en)

Inventor

Gary N Buell

Original Assignee

Biogen Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-08-17

Filing date

1983-08-17

Publication date

1984-08-29

1983-08-17 Application filed by Biogen Nv filed Critical Biogen Nv

1984-08-29 Publication of DD212982A5 publication Critical patent/DD212982A5/de

Links

102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 55
108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 55
229920001184 polypeptide Polymers 0.000 title claims abstract description 54
241000283690 Bos taurus Species 0.000 title claims abstract description 35
230000012010 growth Effects 0.000 title claims abstract description 35
238000004519 manufacturing process Methods 0.000 title claims abstract description 25
238000000034 method Methods 0.000 title claims description 34
230000003054 hormonal effect Effects 0.000 claims abstract description 16
108010006025 bovine growth hormone Proteins 0.000 claims description 90
108091028043 Nucleic acid sequence Proteins 0.000 claims description 73
230000014509 gene expression Effects 0.000 claims description 42
238000012217 deletion Methods 0.000 claims description 35
230000037430 deletion Effects 0.000 claims description 35
108090000623 proteins and genes Proteins 0.000 claims description 24
108020004511 Recombinant DNA Proteins 0.000 claims description 5
230000008569 process Effects 0.000 claims description 5
241000700605 Viruses Species 0.000 claims description 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
101710132601 Capsid protein Proteins 0.000 claims description 3
101710094648 Coat protein Proteins 0.000 claims description 3
102000053602 DNA Human genes 0.000 claims description 3
102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 3
101710125418 Major capsid protein Proteins 0.000 claims description 3
101710141454 Nucleoprotein Proteins 0.000 claims description 3
101710083689 Probable capsid protein Proteins 0.000 claims description 3
238000012258 culturing Methods 0.000 claims description 3
210000003527 eukaryotic cell Anatomy 0.000 claims description 2
210000001236 prokaryotic cell Anatomy 0.000 claims description 2
239000005556 hormone Substances 0.000 abstract description 6
229940088597 hormone Drugs 0.000 abstract description 6
235000013372 meat Nutrition 0.000 abstract description 6
230000001965 increasing effect Effects 0.000 abstract description 5
230000004584 weight gain Effects 0.000 abstract description 4
235000019786 weight gain Nutrition 0.000 abstract description 4
230000001195 anabolic effect Effects 0.000 abstract description 3
108020004414 DNA Proteins 0.000 description 67
150000001413 amino acids Chemical class 0.000 description 52
210000004027 cell Anatomy 0.000 description 39
239000013612 plasmid Substances 0.000 description 25
108091026890 Coding region Proteins 0.000 description 23
239000002773 nucleotide Substances 0.000 description 23
239000012634 fragment Substances 0.000 description 22
125000003729 nucleotide group Chemical group 0.000 description 22
108020004705 Codon Proteins 0.000 description 15
239000000203 mixture Substances 0.000 description 15
239000013598 vector Substances 0.000 description 15
239000013604 expression vector Substances 0.000 description 13
239000000872 buffer Substances 0.000 description 12
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
229960000723 ampicillin Drugs 0.000 description 9
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
241000588724 Escherichia coli Species 0.000 description 8
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
239000000122 growth hormone Substances 0.000 description 8
230000000694 effects Effects 0.000 description 7
102000004169 proteins and genes Human genes 0.000 description 7
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
108091081024 Start codon Proteins 0.000 description 6
230000008859 change Effects 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
230000014616 translation Effects 0.000 description 6
108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
JHKXZYLNVJRAAJ-WDSKDSINSA-N Met-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(O)=O JHKXZYLNVJRAAJ-WDSKDSINSA-N 0.000 description 5
241000282887 Suidae Species 0.000 description 5
239000004098 Tetracycline Substances 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
238000003776 cleavage reaction Methods 0.000 description 5
238000011049 filling Methods 0.000 description 5
239000000499 gel Substances 0.000 description 5
108020004999 messenger RNA Proteins 0.000 description 5
230000007017 scission Effects 0.000 description 5
229960002180 tetracycline Drugs 0.000 description 5
229930101283 tetracycline Natural products 0.000 description 5
235000019364 tetracycline Nutrition 0.000 description 5
150000003522 tetracyclines Chemical class 0.000 description 5
238000013519 translation Methods 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
108091028026 C-DNA Proteins 0.000 description 4
108010051696 Growth Hormone Proteins 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
102100038803 Somatotropin Human genes 0.000 description 4
238000005520 cutting process Methods 0.000 description 4
229930027917 kanamycin Natural products 0.000 description 4
229960000318 kanamycin Drugs 0.000 description 4
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
229930182823 kanamycin A Natural products 0.000 description 4
238000002271 resection Methods 0.000 description 4
102000004594 DNA Polymerase I Human genes 0.000 description 3
108010017826 DNA Polymerase I Proteins 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
241001646716 Escherichia coli K-12 Species 0.000 description 3
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
108010076504 Protein Sorting Signals Proteins 0.000 description 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
238000010367 cloning Methods 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
230000001817 pituitary effect Effects 0.000 description 3
238000000746 purification Methods 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
230000009466 transformation Effects 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
102000012410 DNA Ligases Human genes 0.000 description 2
108010061982 DNA Ligases Proteins 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
241001288713 Escherichia coli MC1061 Species 0.000 description 2
241000702189 Escherichia virus Mu Species 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
108091034057 RNA (poly(A)) Proteins 0.000 description 2
241000187747 Streptomyces Species 0.000 description 2
108020005038 Terminator Codon Proteins 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
238000003556 assay Methods 0.000 description 2
235000021053 average weight gain Nutrition 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
238000001514 detection method Methods 0.000 description 2
230000029087 digestion Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
239000000284 extract Substances 0.000 description 2
238000000605 extraction Methods 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
108020001507 fusion proteins Proteins 0.000 description 2
102000037865 fusion proteins Human genes 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
230000035772 mutation Effects 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
239000002243 precursor Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
230000028327 secretion Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
241000894007 species Species 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
241000510930 Brachyspira pilosicoli Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000709744 Enterobacterio phage MS2 Species 0.000 description 1
241000617590 Escherichia coli K1 Species 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
206010062767 Hypophysitis Diseases 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
101710149086 Nuclease S1 Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000473945 Theria <moth genus> Species 0.000 description 1
BQBCIBCLXBKYHW-CSMHCCOUSA-N Thr-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])[C@@H](C)O BQBCIBCLXBKYHW-CSMHCCOUSA-N 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
210000004198 anterior pituitary gland Anatomy 0.000 description 1
230000011681 asexual reproduction Effects 0.000 description 1
238000013465 asexual reproduction Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000008468 bone growth Effects 0.000 description 1
210000000234 capsid Anatomy 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
230000007515 enzymatic degradation Effects 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
230000004153 glucose metabolism Effects 0.000 description 1
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000003189 isokinetic effect Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
230000008216 juvenile development Effects 0.000 description 1
230000037356 lipid metabolism Effects 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
239000003550 marker Substances 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000036651 mood Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
150000003833 nucleoside derivatives Chemical class 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
239000000047 product Substances 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 description 1
150000003254 radicals Chemical class 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
101150079601 recA gene Proteins 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
238000012552 review Methods 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
210000002303 tibia Anatomy 0.000 description 1
238000012546 transfer Methods 0.000 description 1
108010080629 tryptophan-leucine Proteins 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
229940035893 uracil Drugs 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/168—Steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/30—Signal or leader sequence

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Polymers & Plastics (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Animal Husbandry (AREA)
Food Science & Technology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Feed For Specific Animals (AREA)
Fodder In General (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Steroid Compounds (AREA)

DD83254030A 1982-08-17 1983-08-17 Verfahren zur herstellung von rinder-wachstumshormon-aehnlichen polypeptiden DD212982A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB8223695		1982-08-17

Publications (1)

Publication Number	Publication Date
DD212982A5 true DD212982A5 (de)	1984-08-29

Family

ID=10532360

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD83254030A DD212982A5 (de)	1982-08-17	1983-08-17	Verfahren zur herstellung von rinder-wachstumshormon-aehnlichen polypeptiden

Country Status (12)

Country	Link
US (1)	US4693973A (fr)
EP (1)	EP0103395A3 (fr)
JP (1)	JPS5963197A (fr)
AU (1)	AU568597B2 (fr)
CA (1)	CA1224432A (fr)
DD (1)	DD212982A5 (fr)
DK (1)	DK375283A (fr)
ES (1)	ES8502476A1 (fr)
NO (1)	NO832948L (fr)
NZ (1)	NZ205212A (fr)
PT (1)	PT77206B (fr)
ZA (1)	ZA835880B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ201918A (en) *	1981-09-18	1987-04-30	Genentech Inc	N-terminal methionyl analogues of bovine growth hormone
US5254463A (en) *	1981-09-18	1993-10-19	Genentech, Inc.	Method for expression of bovine growth hormone
EP0111814A3 (fr) *	1982-12-16	1985-08-14	Mgi Pharma, Inc.	Clonage et expression de séquences de nucléotides codant pour l'hormone de croissance bovine
BG49718A3 (bg) *	1983-07-15	1992-01-15	Bio- Technology General Corp	Метод за получаване на полипептид със супероксиддисмутазна активност
US4935370A (en) *	1983-12-23	1990-06-19	Pfizer Inc.	Expression plasmids for improved production of heterologous protein in bacteria
DE3585170D1 (de) *	1984-03-06	1992-02-27	Lilly Co Eli	Expressionsvektoren fuer rinderwachstumshormonderivate.
US5489529A (en) *	1984-07-19	1996-02-06	De Boer; Herman A.	DNA for expression of bovine growth hormone
US5141922A (en) *	1985-02-22	1992-08-25	Monsanto Company	Biologically active proteins and a method for their use
US4861868A (en) *	1985-02-22	1989-08-29	Monsanto Company	Production of proteins in procaryotes
US5037806A (en) *	1985-02-22	1991-08-06	Monsanto Company	Biologically active method using somatotropins
US4670249A (en) *	1985-04-12	1987-06-02	International Minerals & Chemical Corp.	Growth-promoting compositions
ATE76435T1 (de)	1985-06-26	1992-06-15	Upjohn Co	Solubilisation und oxidation von somatotropin aus transformierten mikroorganismen.
US4788144A (en) *	1985-06-28	1988-11-29	International Minerals & Chemical Corp.	Fermentation process for the high level production of swine growth
US4762784A (en) *	1985-07-15	1988-08-09	International Minerals & Chemical Corp.	Fermemtation process for the high level production of bovine growth hormone
US4786501A (en) *	1985-07-15	1988-11-22	International Minerals & Chemical Corp.	Cylindrical implants for the controlled release of growth hormones
AU599922B2 (en) *	1985-09-10	1990-08-02	Natinco Nv	Improving carcass quality
US5631227A (en) *	1985-09-18	1997-05-20	The Upjohn Company	Somatotropin analogs
NZ218148A (en) *	1985-11-08	1989-06-28	Smithkline Beckman Corp	E.coli expression vector coding for alpha-1-antitrypsin
US4892764A (en) *	1985-11-26	1990-01-09	Loctite Corporation	Fiber/resin composites, and method of making the same
US5366876A (en) *	1986-12-31	1994-11-22	Lucky Ltd.	Method for production of bovine growth hormone using a synthetic gene
JPH0712318B2 (ja) *	1986-12-31	1995-02-15	株式会社ラッキー	合成遺伝子を使用したウシ成長ホルモンの製造方法
EP0279616A3 (fr) *	1987-02-17	1990-03-07	International Minerals And Chemical Corporation	Augmentation de la croissance du porc
US5240837A (en) *	1987-02-19	1993-08-31	The Upjohn Company	CDNAS encoding somatotropin, expression vectors and hosts
US5104806A (en) *	1987-03-12	1992-04-14	Amgen, Inc.	Porcine growth hormone analogs encoding dna
WO1988007084A1 (fr) *	1987-03-12	1988-09-22	Amgen Inc.	Analogues de somathormone bovine
US4888416A (en) *	1987-03-30	1989-12-19	International Minerals & Chemical Corp.	Method for stabilizing somatotropins
US5063158A (en) *	1987-11-09	1991-11-05	Eli Lilly And Company	Recombinant DNA expression vector comprising both transcriptional and translational activating sequences
US5192669A (en) *	1987-11-09	1993-03-09	Eli Lilly And Company	Method to produce recombinant proteins using an expression vector comprising transcriptional and translational activating sequences
US5268284A (en) *	1988-03-11	1993-12-07	The Upjohn Company	Ribosome binding site
ATE154364T1 (de)	1988-09-02	1997-06-15	Univ Rockefeller	Makrophagenabgeleiteter entzündungsmediator(mip- 2)
US5079230A (en) *	1988-09-12	1992-01-07	Pitman-Moore, Inc.	Stable bioactive somatotropins
EP0363063A3 (fr) *	1988-09-29	1990-07-25	Bunge (Australia) Proprietary Limited	Hormone de croissance ovine
WO1990005185A1 (fr) *	1988-11-07	1990-05-17	L'universite De L'etat A Liege	Hormone de croissance humaine modifiee
US5958879A (en) *	1989-10-12	1999-09-28	Ohio University/Edison Biotechnology Institute	Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal
US6583115B1 (en)	1989-10-12	2003-06-24	Ohio University/Edison Biotechnology Institute	Methods for treating acromegaly and giantism with growth hormone antagonists
US6787336B1 (en)	1989-10-12	2004-09-07	Ohio University/Edison Biotechnology Institute	DNA encoding growth hormone antagonists
US5350836A (en) *	1989-10-12	1994-09-27	Ohio University	Growth hormone antagonists
US5266477A (en) *	1990-02-02	1993-11-30	Pitman-Moore, Inc.	Monoclonal antibodies which differentiate between native and modified porcine somatotropins
DE69231467T2 (de)	1991-05-10	2001-01-25	Genentech, Inc.	Auswählen von agonisten und antagonisten von liganden
GB2273931A (en) *	1992-09-28	1994-07-06	Unilever Plc	Mutant polypeptides
DE69435280D1 (de)	1993-03-10	2010-04-15	Glaxosmithkline Llc	Phosphodiesterase des menschlichen Gehirns und Screening-Verfahren
SE9303068D0 (sv) *	1993-09-21	1993-09-21	Kabi Pharmacia Ab	New use
US5767080A (en) *	1996-05-01	1998-06-16	Cargill, Incorporated	Enhanced milk production in dairy cattle
ZA9711733B (en)	1996-12-31	1998-07-01	Monsanto Co	Method for solubilization and naturation of somatotropins
US6087128A (en) *	1998-02-12	2000-07-11	Ndsu Research Foundation	DNA encoding an avian E. coli iss
US20050256239A1 (en) *	2004-05-11	2005-11-17	Lee Chun D	White polyolefin compositions having reduced die drool
CN107446943A (zh) *	2017-09-12	2017-12-08	浙江华军药业有限公司	重组牛生长激素的表达方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3265579A (en) *	1964-01-08	1966-08-09	Upjohn Co	Process for purification of bovine growth hormone
US3308027A (en) *	1965-05-13	1967-03-07	Upjohn Co	Bovine pituitary growth hormone process
US3664925A (en) *	1970-02-20	1972-05-23	Martin Sonenberg	Clinically active bovine growth hormone fraction
US4056520A (en) *	1972-03-31	1977-11-01	Research Corporation	Clinically active bovine growth hormone fraction
NZ187300A (en) *	1977-05-27	1982-08-17	Univ California	Dna transfer vector and micro-organism modified to contain a nucleotide sequence equivalent to the gene of a higher organism
IE48385B1 (en) *	1978-08-11	1984-12-26	Univ California	Synthesis of a eucaryotic protein by a microorganism
US4443539A (en) *	1980-02-05	1984-04-17	The Upjohn Company	Process for preparing bovine growth hormone
IL59690A (en) *	1980-03-24	1983-11-30	Yeda Res & Dev	Production of bovine growth hormone by microorganisms and modified microorganisms adapted to produce it
IE52755B1 (en) *	1980-08-26	1988-02-17	Univ California	Bovine pre-growth and growth hormone
FI821466A7 (fi) *	1981-04-29	1982-10-30	Biogen Nv	Bacillus-kloonausvektorit, yhdistelmä- DNA-molekyylit, niiden transformoimat Bacillus-isännät sekä menetelmätvieraiden DNA- sekvenssien ekspressiota varten sekä näiden koodaamien polypeptidien tuottamiseksi.
JPS58996A (ja) *	1981-06-01	1983-01-06	ザ・ボ−ド・オブ・トラステイ−ズ・ミシガンステ−トユニバ−シテイ−	細菌中での牛成長ホルモン遺伝子のクロ−ン化
NZ201918A (en) *	1981-09-18	1987-04-30	Genentech Inc	N-terminal methionyl analogues of bovine growth hormone
US4371462A (en) *	1982-01-21	1983-02-01	Genex Corporation	Method for purification of anterior pituitary hormones

1983
- 1983-08-08 EP EP83304574A patent/EP0103395A3/fr not_active Withdrawn
- 1983-08-08 CA CA000434118A patent/CA1224432A/fr not_active Expired
- 1983-08-10 ZA ZA835880A patent/ZA835880B/xx unknown
- 1983-08-11 US US06/522,357 patent/US4693973A/en not_active Expired - Fee Related
- 1983-08-11 NZ NZ205212A patent/NZ205212A/en unknown
- 1983-08-16 ES ES524971A patent/ES8502476A1/es not_active Expired
- 1983-08-16 PT PT77206A patent/PT77206B/pt unknown
- 1983-08-16 DK DK375283A patent/DK375283A/da not_active Application Discontinuation
- 1983-08-16 NO NO832948A patent/NO832948L/no unknown
- 1983-08-16 JP JP58148857A patent/JPS5963197A/ja active Pending
- 1983-08-16 AU AU18021/83A patent/AU568597B2/en not_active Ceased
- 1983-08-17 DD DD83254030A patent/DD212982A5/de unknown

Also Published As

Publication number	Publication date
AU568597B2 (en)	1988-01-07
ZA835880B (en)	1984-04-25
ES524971A0 (es)	1985-01-01
JPS5963197A (ja)	1984-04-10
EP0103395A2 (fr)	1984-03-21
NZ205212A (en)	1987-03-31
CA1224432A (fr)	1987-07-21
ES8502476A1 (es)	1985-01-01
US4693973A (en)	1987-09-15
AU1802183A (en)	1984-02-23
PT77206B (en)	1986-06-02
DK375283D0 (da)	1983-08-16
NO832948L (no)	1984-02-20
PT77206A (en)	1983-09-01
EP0103395A3 (fr)	1985-05-22
DK375283A (da)	1984-02-18

Publication	Publication Date	Title
DE3486216T2 (de)	1994-02-17	Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren.
EP0099084B1 (fr)	1989-05-31	Procédé de préparation d'interféron et des vecteurs d'expression pour celui-ci
DE3280422T2 (de)	1993-05-27	Verfahren und produkte zur leichten mikrobiologischen expression von dns-sequenzen.
DE3111405C2 (fr)	1990-06-21
DE69032743T2 (de)	1999-06-17	Herstellung von fusionsproteinen
DE3486206T2 (de)	1994-02-03	Expressionssysteme für Hefe mit PyK-Promotoren enthaltenden Vektoren und Synthese von Fremdproteinen.
DE69535704T2 (de)	2009-02-12	EXPRESSIONSPLASMIDE, DURCH EINEN osmB PROMOTER REGULIERT
DE69233173T2 (de)	2004-05-27	Herstellung eines Interesse-Proteins in der Milch eines Transgen-Säugetieres
DE3382575T2 (de)	1993-02-11	Dna-sequenzen, rekombinante dna-molekuele und verfahren zur herstellung von schweinewachstumshormonaehnlichen polypeptiden.
EP0103395A2 (fr)	1984-03-21	Séquences d'ADN, molécules recombinantes d'ADN et procédés pour la production de peptides du genre de l'hormone de croissance bovine, avec rendement élevé
DD212267A5 (de)	1984-08-08	Verfahren zur herstellung einer fuer rinderwachstumshormon kodierenden desoxynucleotid-sequenz
DD229427A5 (de)	1985-11-06	Verfahren zur gewinnung eines polypeptids
DE3023627A1 (de)	1981-01-22	Mikrobielle expression von quasi- synthetischen genen
DE3111592A1 (de)	1982-03-11	"zur herstellung von rinderwachstumshormon (rwh) befaehigte staemme von e. coli und ihre verwendung zur herstellung von rwh"
DD284047A5 (de)	1990-10-31	Verfahren zur herstellung einer dna-sequenz, die fuer einen alkohol-oxidose-ii-regulationsbereich einer methylotrophen hefe kodiert
AT389892B (de)	1990-02-12	Dna-sequenz mit einem gen, das fuer human-interleukin-2 codiert
EP0228018A2 (fr)	1987-07-08	Protéine GM-CSF, ses dérivés, sa préparation et son utilisation
DE3852582T2 (de)	1995-05-11	Verfahren zur Präparation von stabilen Zellinien aus transgenen Tieren zur Herstellung bestimmter Proteine, Tumorzellinien und daraus erhaltene Proteine.
DE3485850T2 (de)	1993-01-21	Genfragmente, abgeleitet vom menschlichen immunoglobulin-gen.
DE3485923T2 (de)	1993-03-04	Dna-gen, verfahren zu seiner herstellung und dieses gen enthaltendes plasmid.
DE3688870T2 (de)	1993-12-23	Dns-sequenz.
DE3688816T2 (de)	1993-11-18	Dns-sequenz.
DE69231306T2 (de)	2001-01-11	Fermentationsverfahren zur Herstellung von Peptiden durch einen Wirt
DE3688225T2 (de)	1993-07-22	Herstellung menschlichen somatomedins c.
DE10101962B4 (de)	2006-07-27	DNA-Sequenz mit regulatorischen Bereichen zur Expression von Proteinen